The company intends to create a branded ingredient technology that will be introduced in early 2015 and will target the immune support and sport nutrition markets.
After the launch, this will be the fifth branded patented ingredient technology and will join the company’s NIAGEN, PURENERGY, pTeroPure and ProC3G.
ChromaDex founder and CEO Frank Jaksch said: "There is a very large existing market for immune support products and the acquisition of this patented technology will enable us to provide a new, science-backed ingredient option for our customers."
The company said that the licensed technology covers patented and proprietary preparations from food-grade microalgae that are rich in compounds that activate innate immune cells.
University of Mississippi director of technology management Walt Chambliss said: "ChromaDex is a valued partner of the University of Mississippi and has successfully commercialized other technologies from our School of Pharmacy and the National Center for Natural Products Research."
ChromaDex offers science-based solutions to the nutritional supplement, food and beverage, animal health, cosmetic and pharmaceutical industries.